<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Systemic antibiotics used for the initial treatment of acute otitis media in children</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Systemic antibiotics used for the initial treatment of acute otitis media in children</h1>
<div class="graphic"><div class="figure"><div class="ttl">Systemic antibiotics used for the initial treatment of acute otitis media in children</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1">Antibiotic</td> <td class="subtitle1">Route</td> <td class="subtitle1">Dose</td> <td class="subtitle1">Maximum daily dose</td> </tr> <tr> <td class="subtitle2_left" colspan="4">First-line agents</td> </tr> <tr> <td class="subtitle3_single" colspan="4">Communities with increased prevalence of penicillin-nonsusceptible <em>Streptococcus pneumoniae</em></td> </tr> <tr> <td class="indent3">Amoxicillin</td> <td>Oral</td> <td>90 mg/kg per day in 2 doses</td> <td>3 g/day</td> </tr> <tr> <td class="indent3">Amoxicillin-clavulanate*<sup>¶</sup></td> <td>Oral</td> <td>Amoxicillin 90 mg/kg per day, clavulanate 6.4 mg/kg per day in 2 doses</td> <td>3 g/day (amoxicillin component)</td> </tr> <tr> <td class="indent3">Extended release amoxicillin-clavulanate (for those age ≥16 years*<sup>¶</sup>)</td> <td>Oral</td> <td> <p>Amoxicillin 1 g, clavulanate 62.5 mg every 12 hours, or</p> Amoxicillin 2 g, clavulanate 125 mg every 12 hours</td> <td>4 g/day (amoxicillin component)</td> </tr> <tr> <td class="subtitle3_single" colspan="4">Communities with low prevalence of penicillin-nonsusceptible <em>S. pneumoniae</em></td> </tr> <tr> <td class="indent3">Amoxicillin</td> <td>Oral</td> <td>40 mg/kg per day in 2 or 3 doses</td> <td>3 g/day</td> </tr> <tr> <td class="indent3">Amoxicillin-clavulanate*<sup>¶</sup></td> <td>Oral</td> <td>Amoxicillin 40 mg/kg per day, clavulanate 5.7 mg/kg per day in 2 doses<sup>Δ</sup></td> <td>3 g/day (amoxicillin component)</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Alternatives for children with mild non-IgE-mediated reactions to penicillins (ie, without anaphylaxis, bronchospasm, or angioedema)</td> </tr> <tr> <td class="indent2">Cefdinir</td> <td>Oral</td> <td>14 mg/kg per day in 1 or 2 doses</td> <td>600 mg/day</td> </tr> <tr> <td class="indent2">Cefpodoxime</td> <td>Oral</td> <td>10 mg/kg per day in 2 doses</td> <td>400 mg/day</td> </tr> <tr> <td class="indent2">Cefuroxime suspension (no longer available in the United States)<sup>¶</sup></td> <td>Oral</td> <td>30 mg/kg per day in 2 doses</td> <td>1 g/day</td> </tr> <tr> <td class="indent2">Cefuroxime tablets (for children who weigh &gt;17 kg and can swallow the tablet whole)</td> <td>Oral</td> <td>250 mg twice daily</td> <td> </td> </tr> <tr> <td class="indent2">Ceftriaxone<sup>¶</sup></td> <td>Intramuscular or intravenous</td> <td>50 mg/kg per day</td> <td>1 g/day</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Alternatives for children with IgE-mediated or serious delayed reaction<sup>◊</sup> to beta-lactams including cephalosporins</td> </tr> <tr> <td class="indent2">Azithromycin</td> <td>Oral</td> <td>10 mg/kg once on day 1, then 5 mg/kg once per day on days 2 through 5</td> <td>500 mg/day on day 1; 250 mg/day on days 2 through 5</td> </tr> <tr> <td class="indent2">Clarithromycin<sup>§</sup></td> <td>Oral</td> <td>15 mg/kg per day in 2 doses</td> <td>1 g/day</td> </tr> <tr> <td class="indent2">Clindamycin</td> <td>Oral</td> <td>30 mg/kg per day in 3 doses</td> <td>1.8 g/day</td> </tr> </tbody></table></div><div class="graphic_lgnd">This table is meant to be used in conjunction with the UpToDate topics related to acute otitis media in children. Refer to UpToDate content for additional information regarding choice of therapy. The duration of treatment varies with age, associated clinical features, and antimicrobial agent:
<ul class="decimal_heading">
<li>For amoxicillin, amoxicillin-clavulanate, oral cephalosporins, clarithromycin, and clindamycin:
    <ul>
<li>Children &lt;2 years and children (any age) with tympanic membrane perforation or history of recurrent AOM: 10 days</li>
<li>Children ≥2 years with intact tympanic membrane and no history of recurrent AOM: 5 to 7 days</li>
</ul>
</li>
<li>For ceftriaxone: 1 to 3 doses, depending on persistence of symptoms</li>
<li>For azithromycin: 5 days</li>
</ul></div><div class="graphic_footnotes"><p>AOM: acute otitis media; IgE: immunoglobulin E.</p>
<p>* For children at increased risk for beta-lactamase-producing nontypeable <em>Haemophilus influenzae</em>: those who have received a beta-lactam antibiotic (eg, penicillins, cephalosporins) in the previous 30 days, have concomitant purulent conjunctivitis, have a history of recurrent otitis media unresponsive to amoxicillin, or live in a community with high uptake of pneumococcal conjugate vaccine in children.</p>
<p>¶ Frequently used if amoxicillin fails.</p>
<p>Δ The availability of this ratio of amoxicillin to clavulanate (7:1) varies geographically.</p>
<p>◊ IgE-mediated reactions classically begin within 1 hour of the initial or last-administered dose; common features include anaphylaxis, angioedema, wheezing, laryngeal edema, hypotension, and hives/urticaria. Delayed reactions appear after multiple. Examples of serious delayed reactions include Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug-induced cytopenias.</p>
§ Infrequently used because of drug interactions.</div><div id="graphicVersion">Graphic 76491 Version 15.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
